CGEM Cullinan Therapeutics, Inc. Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
02:57
Jul 27
seedy19tron Biotech trader, L/S
The author questions whether the readthrough to CGEM is long given the old name killed a whole.
The author questions whether the readthrough to CGEM is long given the old name killed a whole drug class, expressing skepticism rather than a position.
CGEM
LOW

About CGEM Analyst Coverage

Buzzberg tracks CGEM (Cullinan Therapeutics, Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: seedy19tron.